Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
312 people get OCR articles and Market Currents by email alert.
Get email alerts on OCR »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Looking Into The Specialty Pharmacy SectorDutch Trader • Wed, May 1
-
Omnicare's CEO Hosts Analyst Day Conference Call (Transcript)Sun, Dec 9, 2012
-
Omnicare's CEO Discusses Q3 2012 Results - Earnings Call TranscriptWed, Oct 31, 2012
-
2 Stocks To Trade; What's Next For The MarketThe Oxen Group • Wed, Aug 8, 2012
-
2 Stocks To Trade; What's Next For The MarketThe Oxen Group • Tue, Aug 7, 2012
-
Notable Insider Buys Filed On August 6StockPandit • Tue, Aug 7, 2012
-
Notable Insider Buys Filed On Aug. 1StockPandit • Thu, Aug 2, 2012
To learn more about Seeking Alpha Pro, click here.
-
Omnicare Beats EstimatesZacks Investment Research • Tue, Nov 2, 2010
-
Earnings Preview: OmnicareTheflyonthewall • Wed, Oct 29, 2008
-
Earnings Preview: OmnicareTheflyonthewall • Wed, Jul 30, 2008
-
Earnings Preview: OmnicareTheflyonthewall • Wed, Feb 27, 2008
-
Omnicare Expands China PresenceChinaBio Today • Thu, Feb 21, 2008
-
Glenview Capital Managment Discloses 10% Stake in OmnicareLon Juricic • Wed, Oct 31, 2007
-
ValueAct Capital Bottom-Fishes For Omnicare Inc.Lon Juricic • Fri, Sep 21, 2007
-
Omnicare: Sounds Like Management Was Caught with Its Pants DownGeorge Gutowski • Wed, May 2, 2007
-
The Long Case for OmnicareValue Investor Insight • Thu, Dec 28, 2006
-
Looking Into The Specialty Pharmacy SectorDutch Trader • Wed, May 1
-
2 Stocks To Trade; What's Next For The MarketThe Oxen Group • Wed, Aug 8, 2012
-
2 Stocks To Trade; What's Next For The MarketThe Oxen Group • Tue, Aug 7, 2012
-
Notable Insider Buys Filed On August 6StockPandit • Tue, Aug 7, 2012
-
Notable Insider Buys Filed On Aug. 1StockPandit • Thu, Aug 2, 2012
-
4 Dividend Stocks Hoarding Money But Trading At A DiscountZetaKap • Tue, May 1, 2012
-
Omnicare's CEO Hosts Analyst Day Conference Call (Transcript)Sun, Dec 9, 2012
-
Omnicare's CEO Discusses Q3 2012 Results - Earnings Call TranscriptWed, Oct 31, 2012
-
Omnicare's CEO Discusses Q1 2012 Results - Earnings Call TranscriptFri, Apr 27, 2012
-
Omnicare CEO Discusses Q4 2011 Results - Earnings Call TranscriptThu, Feb 23, 2012
-
Omnicare Inc. - Analyst/Investor DayFri, Dec 9, 2011
-
Omnicare CEO Discusses Q3 2011 Results - Earnings Call TranscriptTue, Oct 25, 2011
-
Omnicare CEO Discusses Q2 2011 Results - Earnings Call TranscriptTue, Jul 26, 2011
-
Omnicare, Inc. Q3 2009 Earnings Call TranscriptFri, Nov 6, 2009
-
Omnicare, Inc., Q4 2008 Earnings Call TranscriptThu, Feb 26, 2009
-
Omnicare Inc. Q3 2008 Earnings Conference Call TranscriptFri, Oct 31, 2008
-
Omnicare, Inc. Q2 2008 Earnings Call TranscriptWed, Aug 6, 2008
-
Omnicare, Inc. Q1 2008 Earnings Call TranscriptThu, May 8, 2008
-
Omnicare, Inc. Q4 2007 Earnings Call TranscriptTue, Apr 22, 2008
-
Omnicare, Inc. Q4 2007 Earnings Call TranscriptTue, Mar 4, 2008
-
Omnicare, Inc. Q3 2007 Earnings Call TranscriptThu, Nov 1, 2007
-
at CNBC.com (Mar 6, 2013)
-
at CNBC.com (Oct 8, 2012)
-
at MarketWatch.com (Jun 11, 2012)
-
at CNBC.com (Jun 11, 2012)
-
at MarketWatch.com (Jun 11, 2012)
-
at MarketWatch.com (Jun 8, 2012)
-
at MarketWatch.com (Feb 23, 2012)
-
at MarketWatch.com (Jan 30, 2012)
-
at MarketWatch.com (Jan 30, 2012)
-
at MarketWatch.com (Jan 27, 2012)
-
Business Wire (Jan 27, 2012)
-
at MarketWatch.com (Jan 12, 2012)
-
Business Wire (Dec 16, 2011)
-
at MarketWatch.com (Dec 2, 2011)
-
at MarketWatch.com (Oct 4, 2011)
-
at MarketWatch.com (Aug 23, 2011)
-
at CNBC.com (Aug 23, 2011)
-
at CNBC.com (Aug 23, 2011)
-
at CNBC.com (May 25, 2011)
-
at CNBC.com (Dec 3, 2010)
OCR vs. ETF Alternatives
Company Description
Omnicare was formed in 1981. Today, Omnicare is a leading pharmaceutical services company. We are the nation’s largest provider of pharmaceuticals and related pharmacy and ancillary services to long-term healthcare institutions. Our clients include primarily skilled nursing facilities... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, April 24, 7:19 AM Omnicare (OCR): Q1 EPS of $0.90 beats by $0.05. Revenue of $1.53B misses by $0.01B. (PR) Comment! [Earnings, Breaking News]
- Wednesday, April 24, 12:05 AM Notable earnings before Wednesday’s open: ABB, ABX, ASH, ATI, AVY, BA, BYD, CFR, CKSW, COR, CP, CS, CVE, DPS, EDU, ELN, EMN, ERIC, F, FDML, GD, GLW, GRA, HCBK, HES, ICON, LAD, LL, LLY, LO, MDCO, MSI, MTH, NDAQ, NOC, NS, NVS, NYCB, OC, OCR, OSIS, PG, PLD, PX, RES, ROK, S, SO, SVU, TEL, TKR, TMO, TROW, TUP, USG, VLY, VMED, WAB, WHR, WLP, WM, WYN Comment! [Earnings]
- Tuesday, April 23, 5:30 PM Notable earnings before Wednesday’s open: ABB, ABX, ASH, ATI, AVY, BA, BYD, CFR, CKSW, COR, CP, CS, CVE, DPS, EDU, ELN, EMN, ERIC, F, FDML, GD, GLW, GRA, HCBK, HES, ICON, LAD, LL, LLY, LO, MDCO, MSI, MTH, NDAQ, NOC, NS, NVS, NYCB, OC, OCR, OSIS, PG, PLD, PX, RES, ROK, S, SO, SVU, TEL, TKR, TMO, TROW, TUP, USG, VLY, VMED, WAB, WHR, WLP, WM, WYN Comment! [Earnings]
- Tuesday, April 16, 5:48 PM Amgen (AMGN) has agreed to to pay $24.9M to settle allegations that it violated the False Claims Act by paying kickbacks to long-term care pharmacy providers to entice them to use its Aranesp anemia drug instead of a rival medicine. The DoJ claims the payments were made to Omnicare (OCR), PharMerica (PMC) and Kindred Healthcare (KND) in return for implementing "therapeutic interchange" programs that were designed to switch Medicare and Medicaid beneficiaries from a competitor drug to AMGN's Aranesp. Comment! [Healthcare]
- Tuesday, February 19, 11:32 AM Omnicare (OCR -0.6%) slips despite a Q4 earnings beat across the board. Net earnings rose 89% as the nursing-home pharmacy company benefited from stronger margins and lower litigation-related charges, but that also masked a 7.3% revenue decline in its long-term-care segment, its largest contributor. Sales in the smaller specialty-care group climbed 25% to $346M. Comment! [Healthcare, Earnings]
- Tuesday, February 19, 7:08 AM Omnicare (OCR): Q4 EPS of $0.86 beats by $0.,01. Revenue of $1.53B beats by $20M. (PR) Comment! [Earnings, Breaking News]
- Wednesday, October 31, 2012, 8:57 AM Omnicare (OCR): Q3 EPS of $0.86 beats by $0.13. Revenue of $1.5B (-2.8% Y/Y) misses by $40M. (PR) Comment! [Earnings]
- Friday, September 14, 2012, 5:44 AM Omnicare (OCR) yesterday named interim CEO John Workman to the top job permanently to replace John Figueroa, who left in June. Workman had been CFO at the company, which supplies nursing homes with drugs, and so he'll be replaced by Robert Kraft. Omnicare also doubled its dividend to $0.14 a share and increased its buyback program by $350M, taking the total approved to $498M. Comment! [Healthcare]
- Wednesday, July 25, 2012, 8:14 AM Omnicare (OCR): Q2 EPS of $0.83 beats by $0.15. Revenue of $1.54B (-1.3% Y/Y) misses by $20M. (PR) Comment! [Earnings]
- Wednesday, July 25, 2012, 12:05 AM Notable earnings before Wednesday’s open: ALXN, AOL, ARMH, ATI, BA, BMY, CAT, CBE, COP, CP, CVE, DAL, DLR, DRH, ECA, ELN, F, GD, GLW, HCBK, HES, JBLU, LCC, LLY, LO, LVLT, MSI, MT, NDAQ, NLSN, NOC, NYB, OCR, PDS, PEP, PX, REGN, ROK, SO, SWI, TEL, TMO, TROW, UMC, USG, WLP, WYN Comment! [Earnings]
- Tuesday, July 24, 2012, 5:30 PM Notable earnings before Wednesday’s open: ALXN, AOL, ARMH, ATI, BA, BMY, CAT, CBE, COP, CP, CVE, DAL, DLR, DRH, ECA, ELN, F, GD, GLW, HCBK, HES, JBLU, LCC, LLY, LO, LVLT, MSI, MT, NDAQ, NLSN, NOC, NYB, OCR, PDS, PEP, PX, REGN, ROK, SO, SWI, TEL, TMO, TROW, UMC, USG, WLP, WYN Comment! [Earnings]
- Monday, June 11, 2012, 2:02 PM Omnicare (OCR -7.4%) shares tumble after the healthcare services company's CEO John Figueroa abruptly quits, and the company provides no explanation. CFO John Workman, will serve as interim CEO as the board searches for a permanent replacement. Comment! [Healthcare, On the Move]
- Monday, June 11, 2012, 5:35 AM J&J (JNJ) may announce this week that it has agreed to pay up to $2.2B to settle investigations into how it marketed its Risperdal antipsychotic treatment and other drugs, and claims it paid kickbacks to Omnicare (OCR), Bloomberg reports. The company will make a misdemeanor plea, with the deal including a criminal penalty of as much as $600M. 3 Comments [Healthcare, Top Stories]
- Friday, June 8, 2012, 4:59 PM Johnson & Johnson (JNJ) says it expects to incur a special charge in Q2 of ~$600M to increase its accrual for the potential settlement of previously disclosed civil litigation matters related to Risperdal, Invega, Natrecor and Omnicare (OCR). Comment! [Healthcare]
- Thursday, April 26, 2012, 11:16 AM Omnicare (OCR): Q1 EPS of $0.81 beats by $0.13. Revenue of $1.59B (+4.5% Y/Y). (PR) Comment! [Earnings]
- Thursday, April 26, 2012, 8:26 AM Omnicare (OCR): Q1 EPS of $0.81 beats by $0.13. Revenue of $1.29B (+4.5% Y/Y). (PR) Comment! [Earnings]
-
Dividend Sheet
Dividend Yields - Stock, Capital, Investment: Best Yielding Drugs Wholesale Stocks ++ http://t.co/kMEPoWa ++ $CAH $ABC $MCK $OCR - View all 0 replies
LATEST REPLIES



